The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 165, Issue 6, Pages 865-869
Publisher
Wiley
Online
2014-04-12
DOI
10.1111/bjh.12888
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials
- (2013) Francesco Rodeghiero et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The biology of thrombopoietin and thrombopoietin receptor agonists
- (2013) David J. Kuter INTERNATIONAL JOURNAL OF HEMATOLOGY
- Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
- (2013) Bahareh Ghadaki et al. TRANSFUSION
- TPO-receptor agonists in ITP: A clinician's navigation between scylla and charybdis
- (2012) Francesco Rodeghiero AMERICAN JOURNAL OF HEMATOLOGY
- How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
- (2012) W. Ghanima et al. BLOOD
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
- (2012) M. N. Saleh et al. BLOOD
- Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
- (2012) James B. Bussel et al. BRITISH JOURNAL OF HAEMATOLOGY
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia
- (2012) Vishwanath K. Mahabir et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
- (2012) Nezam H. Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
- (2012) Matthew J. Olnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
- (2011) M. Khellaf et al. BLOOD
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
- (2010) W. Bao et al. BLOOD
- Biology and Chemistry of Thrombopoietic Agents
- (2010) David J. Kuter SEMINARS IN HEMATOLOGY
- New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura
- (2009) Alan T Nurden et al. LANCET
- Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
- (2008) J. B. Bussel et al. BLOOD
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started